Login / Signup

Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults.

Simone BelmontiBarbara RossettiSara ModicaLorenzo PaglicciAlberto BorghettiArturo CicculloChiara PicarelliRoberto CaudaAndrea De LucaFrancesca MontagnaniFrancesca Lombardi
Published in: Infectious diseases and therapy (2019)
ClinicalTrials.gov identifier, NCT02123433.
Keyphrases
  • hiv infected
  • antiretroviral therapy
  • human immunodeficiency virus
  • hepatitis c virus